Science

Single Protein Discovery Could Unlock More Effective CAR T-Cell Cancer Therapy

Researchers identify NFIL3 as key factor causing engineered immune cells to lose cancer-fighting power, opening path to improved treatments.

Single Protein Discovery Could Unlock More Effective CAR T-Cell Cancer Therapy
Read the full reporting at ScienceDaily Top.

Originally reported by ScienceDaily Top.

CAR T-cell therapy cancer treatment NFIL3 protein immunotherapy CRISPR Columbia University